EcoDrugPlus

Receptor Activity Modifying Protein 1

Ensembl ID : ENSOJAG00000003870
Gene Symbol: RAMP1
1 Cross references
191 Possible Orthologues:

Receptor Activity Modifying Protein 1

Ensembl ID : ENSOJAG00000010777
Gene Symbol: RAMP1
1 Cross references
184 Possible Orthologues:

Renin

Ensembl ID : ENSOJAG00000021013
Gene Symbol: REN
1 Cross references
219 Possible Orthologues:

Ret Proto-Oncogene Receptor Tyrosine Kinase

Ensembl ID : ENSOJAG00000020105
Gene Symbol: RET
1 Cross references
205 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSOJAG00000013587
Gene Symbol: RARB
1 Cross references
393 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSOJAG00000017981
Gene Symbol: RARG
1 Cross references
353 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 2a

Ensembl ID : ENSOJAG00000018887
Gene Symbol: ROCK2A
1 Cross references
225 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 2b

Ensembl ID : ENSOJAG00000021566
Gene Symbol: ROCK2B
1 Cross references
225 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSOJAG00000006550
Gene Symbol: RPL11
1 Cross references
288 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSOJAG00000000797
Gene Symbol: RPL12
1 Cross references
478 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSOJAG00000021538
Gene Symbol: RPL13A
1 Cross references
368 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSOJAG00000011097
Gene Symbol: RPL14
1 Cross references
309 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).